$OHI

Ballew Neal sold (to issuer) $524 of OHI

Ballew Neal (CHIEF ACCOUNTING OFFICER) sold (to issuer) 11 shares of OMEGA HEALTHCARE INVESTORS INC (OHI) at $47.68 on 2026-07-01.

Original reporting
SEC EDGAR · Ballew Neal
Published Jul 1, 2026, 8:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 1, 2026, 9:03 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$OHI
Neutral
medium confidence
Mentioned
$OHI
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OHINeutralLow
01

Why it matters

The disclosure updates ownership records for the CFO but does not include any new company performance, guidance, or strategic event.

02

Market read

Traders may note the insider transaction, but the small value and lack of fundamental context make it unlikely to drive trading decisions.

03

What to watch

Insider sales to the issuer often occur via pre-set corporate mechanics (e.g., buyback participation), and the filing provides no new fundamentals.

Relevance 3/10Novelty 2/10Timing: filed 2026-07-01 (after-hours)

Background

The article is an SEC Form 4 insider transaction disclosure for OHI.

Company-level read

Ticker impact

$OHINeutralMedium confidence
Context

OHI disclosed an insider Form 4: CFO Ballew Neal sold 11 shares to the issuer at $47.6800 on 2026-07-01.

Expected impact

Likely negligible near-term impact; treat as compliance/administrative rather than a directional signal.

Evidence & confidence

The filing is a Form 4 insider transaction with small dollar value ($524) and no accompanying operational or guidance change.

Market effects

No sector read-through; this is a single-company insider transaction.

None indicated.

None indicated.

Counterpoint

Absence of a 10b5-1 plan could be interpreted as less “mechanical,” but the transaction size is too small to matter for price discovery.

Key entities

  • OMEGA HEALTHCARE INVESTORS INC

    Subject of the Form 4 insider transaction disclosure.

  • Ballew Neal

    Chief Accounting Officer who sold 11 shares to the issuer on 2026-07-01.

Related articles

$OHIMed

Omega Healthcare Investors (OHI) Q2 2026 Earnings Call Transcript

Omega Healthcare Investors (OHI) discussed its Q2 2026 earnings call, focusing on portfolio resilience in skilled nursing and senior housing and capital allocation. It reported Q1 adjusted FFO of $0.83 per share and FAD of $0.78, flat sequentially due to $563 million asset sales. OHI cited 6.7% cap-rate dispositions, operator EBITDAR coverage of 1.65x (as of Mar 31, 2026), a $16 million DIP paydown, and a $480 million CommuniCare asset exit.

$OHIMed

Omega Healthcare Investors Q2 Earnings Call Highlights

Omega Healthcare Investors (OHI) reported Q2 adjusted funds from operations (AFFO) of $261 million, or $0.83/share, and FAD of $248 million, or $0.78/share. The company completed $377 million in new investments and used about $700 million in asset-sale proceeds and loan repayments to cut revolver borrowings to $6 million. OHI raised 2026 AFFO guidance to $3.22-$3.26/share and expects a temporary earnings headwind from late Q2 closings.

$OHIMed

OMEGA HEALTHCARE INVESTORS INC (OHI): Results of Operations and Financial Condition

OMEGA HEALTHCARE INVESTORS INC (OHI) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ohi-20260729xex99d1.htm EX-99.1 Exhibit 99.1 ​ 303 International Circle P : 410.427.1700 Suite 200 Hunt Valley, MD 21030 ​ PRESS RELEASE – FOR IMMEDIATE RELEASE OMEGA REPORTS SECOND QUARTER 2026 RESULTS AND RECENT DEVELOPMENTS Completed $126 Million in New Investments i

$GOODHighAI 9/10

F&P Healthcare weighs on NZX50 ahead of earnings

New Zealand’s S&P/NZX 50 fell 0.2% to 12,970.28 as exporters and property stocks were broadly weaker ahead of Fisher & Paykel Healthcare’s annual earnings on Tuesday and Goodman New Zealand’s results. F&P shares slipped 1.3% to $33.66. Oceania Healthcare rose 2.8% after brokers lifted targets. Outside the index, Pacific Edge gained 3.7% while Eroad fell 8% after missing guidance; Ampfield seeks board control.